Upcoming webinar “Best practice in dose-finding studies”

Metronomia warmly invites you to join our webinar series on excellence in clinical trials: On 4th of April 2017, an expert panel of Metronomia Statisticians will discuss state of the art dose finding approaches in phase I and II clinical trials.


Webinar description: 


More than 40% of phase III studies fail due to a lack of efficacy. This very costly exercise could be significantly improved by better early-development programs, including appropriate dose-finding studies.


This Metronomia webinar will provide you with insights into state-of-the-art dose-finding strategies in phase I and II clinical trials, including Bayesian methods and MCP-Mod (incl. methodological aspects, requirements, experiences) – enabling you to achieve more with your dose-finding activities and increase your chances for success in phase III.


The webinar will commence on the 4th of April 2017, at 3pm CET (duration: 45 minutes).


The Metronomia expert panel presenting this webinar has more than 30 years of experience in clinical research and statistical consulting: 

  • Dorothea Wessiepe, MSc, Director Biostatistics
  • Simon Rückinger, PhD, Associate Director Biostatistics
  • Lisa Möst, PhD, Senior Statistician

Click here to register for the webinar


For further information about Metronomia, please visit www.metronomia.net

Metronomia ist eine CRO für Datenmanagement, Biostatistik und statistische Beratung in klinischen Studien Phase I – IV und NIS mit Sitz ... [mehr]